about
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAsTelmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney diseaseAlterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney diseaseRenal cyclooxygenase products are higher and lipoxygenase products are lower in early disease in the pcy mouse model of adolescent nephronophthisisPPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney diseaseDietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.Feeding flaxseed oil but not secoisolariciresinol diglucoside results in higher bone mass in healthy rats and rats with kidney disease.Nutritional and health benefits of pulses.Lack of Benefit of Early Intervention with Dietary Flax and Fish Oil and Soy Protein in Orthologous Rodent Models of Human Hereditary Polycystic Kidney DiseaseGeneration of Bioactive Oxylipins from Exogenously Added Arachidonic, Eicosapentaenoic and Docosahexaenoic Acid in Primary Human Brain Microvessel Endothelial Cells.Exogenous arachidonic acid mediates permeability of human brain microvessel endothelial cells through prostaglandin E2 activation of EP3 and EP4 receptors.Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase.COX-2 expression in cystic kidneys is dependent on dietary n-3 fatty acid composition.Dietary LA and sex effects on oxylipin profiles in rat kidney, liver, and serum differ from their effects on PUFAs.Comparative effects of high oleic acid vs high mixed saturated fatty acid obesogenic diets upon PUFA metabolism in mice.Intake patterns and dietary associations of soya protein consumption in adults and children in the Canadian Community Health Survey, Cycle 2.2.Nutrient and Food Group Intakes of Manitoba Children and Youth: A Population-Based Analysis by Pulse and Soy Consumption Status.Folate intakes from diet and supplements may place certain Canadians at risk for folic acid toxicity.Butyrate alters activity of specific cAMP-receptor proteins in a transgenic mouse colonic cell line.Proapoptotic effects of dietary (n-3) fatty acids are enhanced in colonocytes of manganese-dependent superoxide dismutase knockout mice.Purified dietary n-3 polyunsaturated fatty acids alter diacylglycerol mass and molecular species composition in concanavalin A-stimulated murine splenocytes.Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet.Trans-8, cis-10+ cis-9, trans-11-conjugated linoleic acid mixture alters body composition in Syrian golden hamsters fed a hypercholesterolaemic diet.Tyrosol attenuates ischemia-reperfusion-induced kidney injury via inhibition of inducible nitric oxide synthase.High dose trans-10,cis-12 CLA increases lean body mass in hamsters, but elevates levels of plasma lipids and liver enzyme biomarkers.Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6/n-3 FA ratio in experimental polycystic kidney disease.Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease.Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat.Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat.Pulse consumption in Canadian adults influences nutrient intakes.Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease.Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys.Dietary restriction in moderately obese rats improves body size and glucose handling without the renal and hepatic alterations observed with a high-protein diet.Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats.Distinct effects of dietary flax compared to fish oil, soy protein compared to casein, and sex on the renal oxylipin profile in models of polycystic kidney disease.Dietary modulation of oxylipins in cardiovascular disease and aging.Diet and disease alter phosphoinositide composition and metabolism in murine polycystic kidneys.Mixed compared with single-source proteins in high-protein diets affect kidney structure and function differentially in obese fa/fa Zucker rats.Protein source in a high-protein diet modulates reductions in insulin resistance and hepatic steatosis in fa/fa Zucker rats.
P50
Q27014988-0F7E3700-916E-41B1-B3B6-358ACF73D513Q28536366-DA757155-B292-4541-A5E2-ADDA4907EABAQ28580281-D811EE35-41BE-4E90-9F52-0F797C6159D4Q28587416-071AEE6D-493F-4D4E-97B3-424FD528B761Q28742454-5CB684EF-A36F-44D0-A88A-AA89C2E04968Q31789453-6E6668F4-45C0-471D-B199-07FC285C35A4Q33280851-2AC093CB-9AAE-41FD-84E7-55EBA36647F1Q34430806-B66C417D-A515-41FD-9647-626172F9CDB0Q36026246-BF3D646A-B64D-4271-A4BF-A4C1BCAE7BBEQ38411920-44D1CE44-FA6A-4BE1-B708-F80FAE740B3AQ38413997-E1CE8BB5-5C1B-46C5-8981-DAF7D4E98FABQ38431311-E3144D25-68A6-45D2-A278-5CDE2F4A9104Q38432618-6E1E8227-851E-4AE7-B89D-210FC08604D0Q38699329-BB6DD182-DCB8-4C8C-84CF-EBA1EB74F4F3Q38836504-030BFC91-2BDC-45B2-9BD1-295DC685BB48Q39064355-E0DA1687-DBEF-45DB-8084-4AE537EB5D5BQ39287272-5A4900CA-19B0-4D30-B879-6B1180A7ED17Q39409120-7EC5D901-6DE1-4884-936F-319CAA93DEDAQ41141364-07C959FA-35D3-4A14-B264-8519F3DFA926Q41456639-09AA896F-C4B4-4261-BBA3-497B347EC283Q42503453-0BE78A53-EDC3-4EB4-BC66-F31E5587B7F3Q42870209-AD898B3B-C666-430C-9DC4-FD41F9162486Q42978080-E2744BBF-9BF9-44BF-8E51-4E266945DCD3Q43979141-49EC89DB-50CD-4522-BB49-74D70E34DEDEQ44184837-DE84D01A-3AA1-49A5-B91D-57CD42F5A234Q44296504-A78B7609-625C-4D0B-90CB-0392B4438830Q44581625-134396B0-825B-4AA3-A238-85D9D140E630Q44845754-C9A56D15-F882-4079-8BFC-9ACC2A9F6F64Q44963019-5BC25F4E-E6CB-4E30-A42F-73510E21E950Q45730887-C66E24A5-CC6D-4EBF-AE2F-3523D783D640Q46017497-49E1C78E-DC5C-4B18-9806-D266D1E58499Q46482223-B08EBE8C-4C57-4AAE-82FB-5E4990EA9AABQ46761410-E58BA84B-81C4-4710-92C7-DBE0FA413E3CQ47399752-F95DB3D0-FD3D-4C9B-930D-7EA5D7348496Q47405232-5B4D14D4-3274-4081-A7BF-888056374536Q47909692-948C98C0-333C-4906-BD91-A1BB431485B3Q48157381-47FDDA13-939C-4D28-8B81-07E14BAC1468Q49178991-A13E230B-17C8-4160-A1B2-F39E27D9ABA9Q50956817-7F92C6F1-7CC6-4C36-899C-A5DC241C06EBQ51293135-97C6C937-A365-441D-BB41-54DF159B4C40
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Harold M Aukema
@nl
Harold M Aukema
@sl
Harold M. Aukema
@en
Harold M. Aukema
@es
type
label
Harold M Aukema
@nl
Harold M Aukema
@sl
Harold M. Aukema
@en
Harold M. Aukema
@es
altLabel
HM Aukema
@en
Harold M Aukema
@en
prefLabel
Harold M Aukema
@nl
Harold M Aukema
@sl
Harold M. Aukema
@en
Harold M. Aukema
@es
P214
P106
P1153
7004220276
P21
P213
0000 0000 7509 1796
P214
P31
P3835
harold-aukema
P496
0000-0002-6982-7239
P735
P7859
viaf-105183064